IL139552A0 - N-benzodioxanylmethyl-1-piperidylmethylamine compounds having affinity for 5-ht receptors - Google Patents
N-benzodioxanylmethyl-1-piperidylmethylamine compounds having affinity for 5-ht receptorsInfo
- Publication number
- IL139552A0 IL139552A0 IL13955299A IL13955299A IL139552A0 IL 139552 A0 IL139552 A0 IL 139552A0 IL 13955299 A IL13955299 A IL 13955299A IL 13955299 A IL13955299 A IL 13955299A IL 139552 A0 IL139552 A0 IL 139552A0
- Authority
- IL
- Israel
- Prior art keywords
- piperidylmethylamine
- benzodioxanylmethyl
- receptors
- affinity
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9811879.7A GB9811879D0 (en) | 1998-06-03 | 1998-06-03 | Therapeutic agents |
| PCT/EP1999/003648 WO1999062902A1 (en) | 1998-06-03 | 1999-05-26 | N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL139552A0 true IL139552A0 (en) | 2002-02-10 |
Family
ID=10833098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13955299A IL139552A0 (en) | 1998-06-03 | 1999-05-26 | N-benzodioxanylmethyl-1-piperidylmethylamine compounds having affinity for 5-ht receptors |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1087964A1 (en) |
| JP (1) | JP2002517392A (en) |
| KR (1) | KR20010052526A (en) |
| CN (1) | CN1304408A (en) |
| AR (1) | AR018622A1 (en) |
| AU (1) | AU4369599A (en) |
| BG (1) | BG104988A (en) |
| BR (1) | BR9910927A (en) |
| CA (1) | CA2333756A1 (en) |
| CO (1) | CO5021190A1 (en) |
| GB (1) | GB9811879D0 (en) |
| HR (1) | HRP20010005A2 (en) |
| HU (1) | HUP0102233A2 (en) |
| ID (1) | ID27067A (en) |
| IL (1) | IL139552A0 (en) |
| NO (1) | NO20006041D0 (en) |
| PL (1) | PL344594A1 (en) |
| SK (1) | SK17602000A3 (en) |
| TR (1) | TR200003569T2 (en) |
| WO (1) | WO1999062902A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9915616D0 (en) * | 1999-07-05 | 1999-09-01 | Knoll Ag | Therapeutic agents |
| GB0007376D0 (en) * | 2000-03-28 | 2000-05-17 | Knoll Ag | Therapeutic agents |
| JP2003532729A (en) * | 2000-05-12 | 2003-11-05 | ソルベイ・フアーマシユーチカルズ・ベー・ブイ | Piperazine and piperidine compounds |
| CA2405758A1 (en) * | 2000-05-12 | 2001-11-15 | Solvay Pharmaceuticals B.V. | Use of compounds having combined dopamine d2, 5-ht1a and alpha adrenoreceptor agonistic action for treating cns disorders |
| JP2008530229A (en) | 2005-02-17 | 2008-08-07 | ワイス | Cycloalkyl fused indole, benzothiophene, benzofuran and indene derivatives |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2681325B1 (en) * | 1991-09-16 | 1993-12-17 | Fabre Medicament Pierre | DERIVATIVES OF AMINOMETHYL-4 PIPERIDINE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION. |
| FR2701479B1 (en) * | 1993-02-11 | 1995-05-12 | Pf Medicament | New heterocyclic derivatives of 4-aminomethyl piperidine, their preparation and their therapeutic use. |
| GB9318431D0 (en) * | 1993-09-06 | 1993-10-20 | Boots Co Plc | Therapeutic agents |
| GB9514380D0 (en) * | 1995-07-13 | 1995-09-13 | Knoll Ag | Therapeutic agents |
-
1998
- 1998-06-03 GB GBGB9811879.7A patent/GB9811879D0/en not_active Ceased
-
1999
- 1999-05-26 CA CA002333756A patent/CA2333756A1/en not_active Abandoned
- 1999-05-26 PL PL99344594A patent/PL344594A1/en not_active Application Discontinuation
- 1999-05-26 WO PCT/EP1999/003648 patent/WO1999062902A1/en not_active Application Discontinuation
- 1999-05-26 EP EP99926434A patent/EP1087964A1/en not_active Ceased
- 1999-05-26 HU HU0102233A patent/HUP0102233A2/en unknown
- 1999-05-26 ID IDW20002519A patent/ID27067A/en unknown
- 1999-05-26 AU AU43695/99A patent/AU4369599A/en not_active Abandoned
- 1999-05-26 BR BR9910927-1A patent/BR9910927A/en not_active IP Right Cessation
- 1999-05-26 KR KR1020007013670A patent/KR20010052526A/en not_active Application Discontinuation
- 1999-05-26 CN CN99806908A patent/CN1304408A/en active Pending
- 1999-05-26 IL IL13955299A patent/IL139552A0/en unknown
- 1999-05-26 TR TR2000/03569T patent/TR200003569T2/en unknown
- 1999-05-26 JP JP2000552113A patent/JP2002517392A/en active Pending
- 1999-05-26 SK SK1760-2000A patent/SK17602000A3/en unknown
- 1999-06-03 CO CO99035020A patent/CO5021190A1/en unknown
- 1999-06-03 AR ARP990102619A patent/AR018622A1/en not_active Application Discontinuation
-
2000
- 2000-11-27 BG BG104988A patent/BG104988A/en unknown
- 2000-11-29 NO NO20006041A patent/NO20006041D0/en not_active Application Discontinuation
-
2001
- 2001-01-02 HR HR20010005A patent/HRP20010005A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BG104988A (en) | 2001-11-30 |
| CA2333756A1 (en) | 1999-12-09 |
| CN1304408A (en) | 2001-07-18 |
| BR9910927A (en) | 2001-02-20 |
| CO5021190A1 (en) | 2001-03-27 |
| SK17602000A3 (en) | 2001-08-06 |
| AR018622A1 (en) | 2001-11-28 |
| AU4369599A (en) | 1999-12-20 |
| HUP0102233A2 (en) | 2002-05-29 |
| WO1999062902A1 (en) | 1999-12-09 |
| HRP20010005A2 (en) | 2001-12-31 |
| JP2002517392A (en) | 2002-06-18 |
| ID27067A (en) | 2001-02-22 |
| EP1087964A1 (en) | 2001-04-04 |
| GB9811879D0 (en) | 1998-07-29 |
| NO20006041L (en) | 2000-11-29 |
| TR200003569T2 (en) | 2001-04-20 |
| NO20006041D0 (en) | 2000-11-29 |
| KR20010052526A (en) | 2001-06-25 |
| PL344594A1 (en) | 2001-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1041486A1 (en) | Oxazole compounds as prostaglandin e2 agonists or antagonists | |
| HUP0102621A3 (en) | Polimer composition for pipes | |
| EP1082320A4 (en) | Novel substituted imidazole compounds | |
| HK1077063A1 (en) | Triazospiro compounds having nociceptin receptor affinity | |
| GB9804734D0 (en) | Compounds | |
| GB9804175D0 (en) | Compounds | |
| GB9826359D0 (en) | Novel receptors | |
| AU3934695A (en) | N-methyl piperazine compounds having dopamine receptor affinity | |
| AU3934595A (en) | Alkyl-substituted compounds having dopamine receptor affinity | |
| IL141166A0 (en) | New compounds | |
| IL138629A0 (en) | Azabicyclic 5ht1 receptor ligands | |
| PL344594A1 (en) | N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors | |
| IL122158A0 (en) | Condensed thiazole derivatives having 5-HT receptor affinity | |
| GB9908266D0 (en) | Coonnector for marine risers | |
| AU1100300A (en) | Piperidyloxadiazoles as dopamine receptor antagonists | |
| GB9910432D0 (en) | compounds | |
| AU3543599A (en) | Receptors | |
| ZA9710576B (en) | 2-imidazolinylaminoindazole compounds useful as alpha-2-adrenoceptor agonists | |
| HUP0101446A3 (en) | New compounds | |
| GB9809217D0 (en) | Compounds | |
| GB9715018D0 (en) | 3-Fluoro-4-aminopiperidine derivatives as 5-HT receptor agonists | |
| IL144726A0 (en) | Method for screening compound having affinity for vitamin d receptor | |
| GB9806513D0 (en) | Membrane-bound receptors | |
| SI1077935T1 (en) | Phenylsulfonamide-phenylethylamines useful as dopamine receptors | |
| GB9813614D0 (en) | Level for drill |